Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00903591 · ClinicalTrials.gov registry record
Study of Radiation Exposure and Bilateral Breast Cancer
A clinical trial of Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 1,699
- Enrollment target
- 6
- Study locations
NCT00903591: Active study of Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00903591 is a study of Breast Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,699 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (39% lower). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00903591, a study of Breast Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 1,699 participants
- Enrollment target
- 6
- Study locations
Study Summary
This study is being done to find out what factors may be related to the risk of getting a second breast cancer among women who already have breast cancer in one breast. It will look at how genes, treatment for breast cancer; including radiation therapy, and the effects of different lifestyle activities, may affect the risk of breast cancer. It will use different processes to find genes that might increase the risk of breast cancer. The results of this study may help to develop better ways to detect, treat and prevent breast cancer. This study will compare women who have breast cancer in both breasts to women who have breast cancer in only one breast.
Conditions Studied
Interventions
- OTHER questionaire, blood or saliva sample
Study Locations (6)
California
- Stanford University - Stanford
Iowa
- University of Iowa - Iowa City
New York
- Memorial Sloan Kettering Cancer Center - New York
Washington
- Fred Hutchinson Cancer Research Center - Seattle
Ontario
- ONTARIO CANCER REGISTRY, Mount Sinai Hospital, Toronto - Toronto
Other
- Danish Cancer Society - Copenhagen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,699 participants |
| Start Date | 2009-05 |
| Est. Completion | 2026-05 |
What the registry record for NCT00903591 still lists
NCT00903591 is an observational study that tracks outcomes without assigning an intervention. Its 1,699 participants enrollment target places it among the larger protocols in the corpus, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (39% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which questionaire, blood or saliva sample is the first listed.
NCT00903591 lists 6 locations in 6 states (California, Iowa, New York).
Frequently Asked Questions
What is clinical trial NCT00903591 about?
NCT00903591 is a clinical study titled "Study of Radiation Exposure and Bilateral Breast Cancer". This study is being done to find out what factors may be related to the risk of getting a second breast cancer among women who already have breast cancer in one breast. It will look at how genes, treatment for breast cancer; including radiation therapy, and the effects of different lifestyle activit...
What is the current status of trial NCT00903591?
This trial is currently active not recruiting. The enrollment target is 1,699 participants. The study started on 2009-05. Estimated completion is 2026-05.
What conditions does trial NCT00903591 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT00903591?
The interventions under investigation include: questionaire, blood or saliva sample (OTHER).
Who is sponsoring clinical trial NCT00903591?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00903591 being conducted?
This trial has 6 study locations across California, Iowa, New York, Washington, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00903591's enrollment target sits among peer trials
1,699 79th of 1224 higher than 1,146 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04321200 · 1,700 participants
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
- NCT06238622 · 1,700 participants · Phase 3
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
- NCT07284901 · 1,700 participants · Phase 3
Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- NCT07304531 · 1,705 participants
First To Know Pregnancy Test - Clinical Evaluation Protocol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia